Employers are under pressure to make short-term decisions about obesity treatment, but the bigger challenge is managing long-term cardiometabolic risk. This opening keynote reframes obesity within a broader cardiometabolic context—connecting diabetes, cardiovascular disease, and downstream workforce impact—and sets the lens for the strategic decisions employers will face in 2026 and beyond.